[go: up one dir, main page]

WO1998058842A1 - Method for sterilizing packages of medical supplies - Google Patents

Method for sterilizing packages of medical supplies Download PDF

Info

Publication number
WO1998058842A1
WO1998058842A1 PCT/JP1998/002735 JP9802735W WO9858842A1 WO 1998058842 A1 WO1998058842 A1 WO 1998058842A1 JP 9802735 W JP9802735 W JP 9802735W WO 9858842 A1 WO9858842 A1 WO 9858842A1
Authority
WO
WIPO (PCT)
Prior art keywords
oxygen
medical device
packaging material
package
oxygen concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP1998/002735
Other languages
French (fr)
Japanese (ja)
Inventor
Akira Otsuka
Kiyoshi Uno
Hidetoshi Hatayama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Gas Chemical Co Inc
Gambro KK
Original Assignee
Mitsubishi Gas Chemical Co Inc
Gambro KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Gas Chemical Co Inc, Gambro KK filed Critical Mitsubishi Gas Chemical Co Inc
Priority to AU80360/98A priority Critical patent/AU8036098A/en
Publication of WO1998058842A1 publication Critical patent/WO1998058842A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08Radiation

Definitions

  • the present invention relates to a method for sterilizing a medical device package and a medical device package sterilized by the method. More specifically, for example, by encapsulating both a medical device and a delayed-acting oxygen scavenger in an oxygen-impermeable material, medical devices that prevent the formation of by-products due to oxidation after radiation sterilization
  • the present invention relates to a method for sterilizing a tool package.
  • radiation sterilization methods such as gamma linear sterilization are widely used as sterilization methods for medical device packages.
  • disposable medical devices such as artificial dialysis machines are sterilized by radiation after being enclosed in packaging materials and delivered to users in that state in order to maintain sterility until just before use.
  • the acetate group constituting the membrane is used. Oxidation produces aldehydes, such as acetoaldehyde and formaldehyde, which may have an adverse effect on patients who are users.
  • the main material of the dialysis machine is plastic, and the strength may decrease due to the oxidization over time due to oxygen excited during radiation sterilization.
  • gamma linear sterilization is a method that can achieve excellent sterilization effects in the presence of oxygen, although it is possible even in the absence of oxygen.
  • an artificial dialyzer is placed in a gas-permeable sterilization bag, which is sterilized by gamma, and then put into an aluminum packaging material while keeping the sterilization bag while maintaining the sterility.
  • the nozzle is inserted into the aluminum packaging material, the air in the packaging material is evacuated by a vacuum pump, and nitrogen gas is injected. This process is performed twice in order to reduce the amount of oxygen removed. After that, the nozzle is pulled out, sealed, and shipped. In this way, the gas permeable The air in the packaging material is replaced with nitrogen gas to remove oxygen without compromising the sterility of the sterilization bag.
  • Japanese Patent Publication No. 5-509496 discloses a method in which a hollow fiber type blood processor and an oxygen scavenger are both sealed in a container made of a gas impermeable material and irradiated with radiation for sterilization.
  • the radiation include gamma rays (Claim 2)
  • examples of the blood processor include a blood processor using a regenerated cellulose hollow fiber membrane (Claim 5).
  • oxygen in the container is absorbed by the oxygen scavenger, and is in an oxygen-free state during sterilization (column 4, line 10, line 15). This publication does not mention that the absence of oxygen during sterilization reduces the sterilization effect.
  • the sterilization effect is obtained by the formation of oxygen radicals during gamma ray irradiation, and that oxygen radicals are obtained by influencing and killing bacteria. It was found that the sterilization effect was obtained even at low oxygen levels. That is, there was no substantial change in the sterilization effect if the oxygen concentration was above 0.1%, preferably above 0.2%, more preferably 1% or above.
  • oxygen radicals formed during sterilization can affect the material of dialysis machines, especially in the case of dialysis machines made from regenerated cellulose, and may generate aldehydes.
  • the present inventors have also found that performing sterilization under a reduced oxygen concentration can suppress the generation of unwanted by-products while maintaining the sterilization effect. That is, when the reduced oxygen concentration is lower than 4-5%, preferably lower than 2%, and more preferably 1% or lower, excellent production conditions are obtained.
  • the present inventors have reached the present invention, and the effects of the present invention can be explained by harmful substances such as aldehydes generated by irradiation for sterilization. That is, according to the sterilization in the reduced oxygen atmosphere of the present invention, almost no such harmful products were generated.
  • radiation sterilization may initiate a reaction that will later produce harmful products under the influence of oxygen.
  • the first object of the present invention is to provide a medical device and an oxygen absorber in an oxygen-impermeable packaging material.
  • a step of performing radiation sterilization on the package while maintaining the atmosphere in the package at a reduced oxygen concentration; maintaining the sterilized state of the package after the radiation sterilization A method of sterilizing a medical device package, further comprising a step of reducing the oxygen concentration with a deoxidizer. Products manufactured in this manner are harmful due to the reduced oxygen atmosphere during sterilization while maintaining the efficiency of sterilization by radiation sterilization, and the reduced oxygen concentration during subsequent storage. It was possible to suppress the generation of by-products, and thus to avoid an increase in irradiation dose.
  • the reduced oxygen concentration is above 0.1%, preferably above 0.2%, more preferably at or above 1%. Further, the reduced oxygen concentration is below 5%, preferably below 4%, more preferably below 2%, even more preferably 1% or below. Furthermore, the reduced oxygen concentration after sterilization is below 0.1%.
  • the method comprises sealing the package under a reduced oxygen concentration atmosphere, and encapsulating the oxygen scavenger in a sealed packaging material having opening means such as breaking means; and Can be carried out by radiation sterilization under a reduced oxygen concentration, then breaking the breaking means and exposing the oxygen absorber to the atmosphere inside the package to further reduce the oxygen concentration.
  • the breaking means may be one that breaks under the influence of radiation sterilization.
  • a preferred method of the present invention is a method in which the oxygen scavenger is sealed in a sustained-release packaging material, whereby the oxygen concentration of the package can be reduced at a constant rate at a certain rate.
  • the package is illuminated when reduced to the desired value.
  • This method provides very favorable manufacturing conditions and provides an improved method with very limited manufacturing steps.
  • the invention also relates to a product made by the method described above.
  • FIG. 1 is a diagram showing an embodiment of the medical device package according to the present invention from above
  • FIG. 2 is a diagram showing an embodiment of the medical device package according to the present invention from the side
  • FIG. 4 is a side view of another embodiment of the medical device package according to the present invention.
  • the medical device and the delayed-acting oxygen scavenger packaging material are both enclosed in a packaging material made of an oxygen-impermeable material.
  • the above-mentioned delayed-acting oxygen scavenger packaging material is a gas-permeable packaging material in which a relatively small air permeability can be obtained stably, in which the oxygen scavenger is stored, and the medical device packaging for radiation sterilization.
  • the body has an oxygen concentration above 0.1%, preferably above 0.2%, more preferably at or above 1%, and below 5%, preferably below 4%. More preferably, the oxygen concentration is controlled to be less than 2%, more preferably 1% or less, and the oxygen concentration after 2 weeks of radiation sterilization is controlled to be less than 0.1%.
  • Radiation sterilization is usually performed within 3 to 7 days after the completion of the production of medical devices.
  • the oxygen concentration in the packaging material is described assuming that radiation sterilization is performed 5 days after the completion of production. This was adopted as a criterion to indicate the degree of delayed action of the oxygen scavenger package and does not mean that radiation sterilization should be performed 5 days after encapsulation.
  • the oxygen concentration can be realized, for example, by controlling the air permeability of the material constituting the packaging material, and various types of resin films made of synthetic polymers or natural polymers, woven fabrics conventionally used in the field of laminates
  • One material having desired air permeability may be selected from nonwoven fabrics and the like, or these materials may be appropriately combined to form a laminate to obtain desired air permeability.
  • a ventilation hole may be provided in some or each layer of the laminate to obtain a desired air permeability. The thickness of each layer is appropriately set.
  • the inner layer perforated plastic film 6 (hereinafter referred to as the inner layer film), because of its low breathability and low danger of the oxygen scavenger leaking out of the packaging material.
  • a cross-sectional breathable sheet 7 and an outer layer plastic film 8 (hereinafter, referred to as an outer layer film) are laminated in this order from the inside of the packaging material containing the oxygen scavenger. Ventilate through the exposed section of the air-permeable sheet at the end section of the packaging material, or reduce the porosity of the outer film to the inner film. It is preferable that a laminated body having a structure in which ventilation is further provided by providing a ventilation hole to control the ventilation is used for at least a part of the packaging material.
  • the porosity (the ratio of the open area to the total area of the outer layer film) is preferably less than 1%.
  • the porosity of the inner layer film is not particularly limited, but is usually 1 to 10%.
  • the oxygen scavenger packaging material is used to reduce the oxygen in the various sizes of packaged goods to which it is applied within two weeks after radiation sterilization within a certain period of deoxidation required to obtain good preservability.
  • the oxygen absorber, the size of the packaging material used for packaging the oxygen absorber, and the air permeability must be changed according to the amount of oxygen present in the article package when the oxygen absorber is enclosed.
  • the air permeability suitable for the delayed-acting oxygen absorber packaging material used in the medical device package of the present invention is as follows: the moisture permeability of the oxygen absorber packaging material is P (mg / 24 Hrs) as a measure of air permeability; Assuming that the amount of oxygen present in the package at the time of packaging is V (ml), the value K represented by the following relational expression is preferably 10 or less, more preferably 8 or less.
  • the moisture permeability P of the oxygen scavenger packaging material was determined by filling a sample filled with anhydrous calcium chloride in place of the oxygen scavenger packaging material (oxygen scavenger) at 25 ° C or lower and 75% RH. Determined by storing within a desiccated overnight humidified condition and measuring the weight gain per sample 24 hours later.
  • Materials for the inner layer film and the outer layer film include polymers of olefins such as ethylene, propylene, butene, pentene, and hexene, vinyl chloride, vinylidene chloride, vinyl acetate, vinyl alcohol, acrylate, and methacrylate. And polymers of vinyl compounds such as acrylonitrile and styrene, polymers of diolefins such as butadiene and isoprene and copolymers thereof, polyamides and polyesters. Of these, polyester, polyamide, and polyolefin are preferred for the outer layer film, and polymers of polyolefin or vinyl compound having a lower melting point than the outer layer film are preferred for the inner layer film so that bag making by heat welding is easy.
  • olefins such as ethylene, propylene, butene, pentene, and hexene
  • vinyl chloride vinylidene chloride
  • vinyl acetate vinyl alcohol
  • acrylate acrylate
  • polyester is more preferably used for the outer layer film
  • polyethylene is more preferably used for the inner layer film.
  • the cross-sectional breathable sheet is a laminate-like sheet that has air permeability in the plane direction at least inside the thickness thereof, and is preferably made of paper or nonwoven fabric, and is printed on the inner surface or outer surface of the outer layer film.
  • a layer may be provided, and a reinforcing layer or the like may be provided at an arbitrary position.
  • the laminate shall be folded or laminated with the perforated plastic film inside, sealed with an oxygen scavenger, and sealed to form a three-sided or four-sided sealed bag.
  • a deoxygenating agent may be sealed in the laminated body, and a non-breathable plastic film may be stacked and sealed to form a four-side seal bag.
  • the sealing may be performed using an adhesive, but it is preferable to heat seal the plastic film as a sealant.
  • oxygen scavenger those mainly containing iron powder, which can use various compounds conventionally used in this field, are preferable.
  • an auxiliary such as a water donor impregnated with water on a porous carrier, activated carbon, or silica may be appropriately selected and added to the oxygen scavenger.
  • any material conventionally used in the field of laminates for example, a metal foil, a metal deposition film, a metal oxide deposition film, a glass deposition film, a vinylidene chloride synthetic resin, Those containing at least one layer of a vinylidene acetate-based synthetic resin, an acrylonitrile-based synthetic resin, or the like can be used.
  • the outer layer is made of nylon
  • the intermediate layer is a laminate of EVOH (ethylene vinyl acetate polymer, saponified)
  • the inner layer is a laminate of polyethylene
  • the outer layer is nylon
  • the intermediate layer is A laminate of polyvinyl alcohol, an inner layer of polyethylene; an outer layer of polyester, an intermediate layer of aluminum foil, and an inner layer of polyethylene are preferred.
  • an artificial dialyzer which has conventionally been considered unsuitable for radiation sterilization, particularly a regenerated cellulose membrane of a hollow fiber membrane type, particularly a cellulose acetate membrane Suitable for use are artificial dialysers that use dialysis and medical devices that are susceptible to adverse effects such as deterioration due to oxygen.
  • Radiation sterilization is used as a sterilization method. Among them, gamma ray sterilization is preferable from the viewpoint of cost.
  • FIGS. 1 and 2 are views showing one embodiment of the medical device package according to the present invention at different angles.
  • the main body of the medical device 1 is sealed together with the oxygen-absorbing material 2 in an oxygen-impermeable material.
  • an oxygen-impermeable laminate sheet (Pairflex FA29I trade name, manufactured by Kureha Chemical Co., Ltd.) used on the bottom side 5 of the packaging material is drawn out of the roll, heated by a heater, and air-heated. And pressed into a mold to form a concave shape with a medical device enclosure as shown in FIG.
  • the oxygen scavenger packaging material 2 (Ageless Z—300 PK gas, moisture permeability of the package 3 O mg / 24 Hr, trade name, product of Mitsubishi Gas Chemical Co., Ltd., manufactured by Mitsubishi Gas Chemical Co., Ltd.) is automatically loaded by the automatic feeding machine. Put in the center of part 5.
  • the medical device is placed on top of it, and the oxygen-impermeable laminate sheet (Boblon, trade name, product of Kureha Chemical Co., Ltd.) used for the packaging material top 3 is pulled out of the roll and the packaging material bottom It is overlapped with the part 5, and the periphery is sealed and sealed by heat sealing (the amount of oxygen at the time of sealing is about 120 ml).
  • the oxygen concentration in the packaging material of the oxygen-impermeable material of the medical device package of this example was 1% at the time of radiation sterilization, and 0.1% or less two weeks after the sterilization.
  • each of the above three test samples is primed and washed with 150 ml of distilled water only on the blood side. Thereafter, 500 ml of distilled water at 37 ° C is circulated at 6:00 at a flow rate of 400 ml / min only on the blood side. This extract is used as a specimen.
  • the measurement is performed by reversed-phase high-performance liquid chromatography using acetoaldehyde and formaldehyde as hydrazone derivatives, a column packed with octyl groups in the stationary phase, and acetonitrile / water as the mobile phase.
  • the packaging material made of an oxygen-impermeable material
  • the oxygen present in the packaging material at the time of sealing is absorbed by the enclosed slow-acting oxygen absorber packaging material at the same time, and the interior of the packaging material is almost completely oxygen-free until the packaging material is opened immediately before use. Can be kept.
  • FIG. 4 is a view showing another embodiment of the medical device package according to the present invention.
  • the oxygen scavenger packaging material 2 ′ has a breaking pin 9 as an opening means.
  • the outer film is impervious to oxygen and breaks the breaking pin 9 until the interior of the oxygen absorber 2 ′ is exposed to the oxygen atmosphere inside the package consisting of the package top 3 and package bottom 5. The oxygen cannot enter the oxygen scavenger 2 '.
  • the by-product from a medical device by time-dependent oxidation for example, the production

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Packages (AREA)

Abstract

A sterilization method which comprises the step of enclosing a medical supply together with a deoxidizer in an oxygen-impermeable packaging material to give a package, the step of sterilizing the package by radiation while maintaining the atmosphere in the package in a state with a reduced oxygen concentration, and the step of, after the completion of the radiation sterilization, further reducing the oxygen concentration with the deoxidizer while maintaining the package under the sterile conditions. In this method, the oxygen concentration can be maintained at a low level during the sterilization while sustaining the sterilization efficiency of the radiation sterilization and the oxygen concentration is also maintained at a low level during the subsequent storage, which makes it possible to inhibit the formation of harmful by-products, thus ensuring the provision of highly safe medical supplies.

Description

明 細 書 医療用具包装体の滅菌方法 技術分野  Description Sterilization method of medical device package Technical field

本発明は医療用具包装体の滅菌方法およびその方法により滅菌された医療用具 包装体に関する。 さらに詳しくは、 たとえば酸素不透過性材質の包材中に医療用 具と遅効性脱酸素剤包剤とを共に封入することによって、 放射線滅菌後の酸化に よる副成物の生成を防止した医療用具包装体の滅菌方法に関する。  The present invention relates to a method for sterilizing a medical device package and a medical device package sterilized by the method. More specifically, for example, by encapsulating both a medical device and a delayed-acting oxygen scavenger in an oxygen-impermeable material, medical devices that prevent the formation of by-products due to oxidation after radiation sterilization The present invention relates to a method for sterilizing a tool package.

背景技術 Background art

現在、 医療用具包装体の滅菌方法としてはガンマ一線滅菌法などの放射線滅菌 法が広く用いられている。 そして例えば人工透析器のような使い捨ての医療用具 は、 使用直前まで滅菌状態を維持するために、 包材に封入後、 放射線滅菌され、 その状態で使用者のもとに届けられている。  At present, radiation sterilization methods such as gamma linear sterilization are widely used as sterilization methods for medical device packages. For example, disposable medical devices such as artificial dialysis machines are sterilized by radiation after being enclosed in packaging materials and delivered to users in that state in order to maintain sterility until just before use.

し力、し、 包材中に酸素が存在すると、 人工透析器において例えば中空糸膜型の セル口一スァセテ一ト膜を使用している場合などにおいて、 膜を構成しているァ セテー卜基から酸化反応によってァセトアルデヒドゃホルムアルデヒドなどのァ ルデヒド類が生成し、 使用者である患者に悪影響を与える可能性がある。 また、 人工透析器の主材料はプラスチックであり、 放射線滅菌時に励起された酸素によ る経時的な酸化によって、 強度が低下するおそれがある。  When oxygen is present in the packaging material, for example, when the hollow fiber membrane type cell mouth-acetate membrane is used in an artificial dialysis machine, the acetate group constituting the membrane is used. Oxidation produces aldehydes, such as acetoaldehyde and formaldehyde, which may have an adverse effect on patients who are users. In addition, the main material of the dialysis machine is plastic, and the strength may decrease due to the oxidization over time due to oxygen excited during radiation sterilization.

これらの酸化に起因する間題を解決するには、 包材中の酸素を取り除く必要が ある。 しかしガンマ一線滅菌は、 酸素の不存在下でも可能ではあるものの酸素存 在下において優れた滅菌効果が得られる方法である。  To solve the problems caused by these oxidations, it is necessary to remove oxygen from the packaging material. However, gamma linear sterilization is a method that can achieve excellent sterilization effects in the presence of oxygen, although it is possible even in the absence of oxygen.

このため従来の方法では、 ガス透過性の滅菌袋に人工透析器を入れ、 それをガ ンマ一線滅菌して、 その後、 無菌性を保ちつつその滅菌袋のままアルミニウム製 包材に入れ、 次いで極細のノズルをアルミニウム製包材中に差し込み、 真空ボン プによって包材中の空気を抜き取り、 窒素ガスを注入している。 酸素の除去量を 增すためにこの工程は 2回行なわれ、 その後、 ノズルを抜き取ったところをシ一 ルし、 出荷している。 このようにして人工透析器が封入されているガス透過性の 滅菌袋中の無菌性を損なうことなく、 包材中の空気を窒素ガスと置換して酸素を 除去している。 For this reason, in the conventional method, an artificial dialyzer is placed in a gas-permeable sterilization bag, which is sterilized by gamma, and then put into an aluminum packaging material while keeping the sterilization bag while maintaining the sterility. The nozzle is inserted into the aluminum packaging material, the air in the packaging material is evacuated by a vacuum pump, and nitrogen gas is injected. This process is performed twice in order to reduce the amount of oxygen removed. After that, the nozzle is pulled out, sealed, and shipped. In this way, the gas permeable The air in the packaging material is replaced with nitrogen gas to remove oxygen without compromising the sterility of the sterilization bag.

し力、しな力 ら、 上記の従来の方法は、 明らかに作業性が悪く生産性も低い。 ま た人工透析器内部の空気まで置換することは困難であるので酸素除去の効率もよ いとはいえない。  However, the conventional methods described above clearly have poor workability and low productivity. Also, it is difficult to replace the air inside the dialysis machine, so the efficiency of oxygen removal is not good.

作業性や生産性を考えて、 あらかじめ滅菌前に脱酸素剤を酸素不透過性材質の 包材中に一緒に入れておくという方法も考え得る力 従来の脱酸素剤を使用する と、 滅菌までに脱酸素が完了してしまうので、 十分な滅菌効果を得るためには、 ガンマ一線量をふやす必要がある。  Considering workability and productivity, it is also conceivable to put the oxygen absorber in the oxygen-impermeable material packaging before sterilization before sterilization. In order to obtain a sufficient sterilization effect, it is necessary to increase the gamma dose by one dose.

また、 血液処理器を滅菌する他の方法が、 特公平 4— 7 0 0 2 3号公報 (U S P 4 , 8 1 3, 2 1 0 ) に開示されている。 この方法は、 まず、 血液処理器をガ ス透過性の袋に入れて滅菌し、 次いで、 その血液処理器の入った袋を脱酸素剤と 共に酸素不透過性の袋に入れ密封する方法であり、 脱酸素剤により酸素が除かれ、 血液処理器の劣化が防がれる。 この公報によれば、 脱酸素剤を存在させてガンマ 一線滅菌を行うと D値、 特に血液処理器がセルロースアセテートの中空糸膜を用 いた血液処理器である場合の D値が大幅に増加することが記載されている (第 5 欄第 5行一第 6欄第 1行) 。 したがって、 この方法によれば、 ガンマ一線滅菌は、 脱酸素剤を存在させずに行うことが好ましいものである。  Another method of sterilizing a blood processing apparatus is disclosed in Japanese Patent Publication No. Hei 4-70023 (USP4, 813, 210). In this method, the blood processor is first placed in a gas-permeable bag for sterilization, and then the bag containing the blood processor is placed in an oxygen-impermeable bag together with a deoxidizer and sealed. Yes, oxygen is removed by the oxygen scavenger, preventing the blood processor from deteriorating. According to this gazette, performing gamma linear sterilization in the presence of an oxygen scavenger significantly increases the D value, especially when the blood processing device is a blood processing device using a cellulose acetate hollow fiber membrane. (Column 5, line 5, line 1, column 6, line 1). Therefore, according to this method, it is preferable that the gamma linear sterilization be performed without the presence of an oxygen scavenger.

さらに、 特公平 5— 5 0 9 4 6号公報には、 中空糸型血液処理器と脱酸素剤を 共にガス不透過性材料製容器に密封し、 放射線を照射して滅菌する方法が開示さ れている。 放射線としてはガンマ線が挙げられ (請求項 2 ) 、 血液処理器として は再生セルロース中空糸膜を用いた血液処理器が挙げられている (請求項 5 ) 。 この発明によれば、 容器内の酸素は脱酸素剤によって吸収され、 滅菌時には無酸 素状態である (第 4欄第 1 0行一第 1 5行) 。 この公報には、 滅菌時に酸素が存 在しないことにより、 滅菌効果が減少することについては何も記載されていない。 放射線はまた、 透析器の材料に影響を与えるものであるから、 放射線量を増加 させることは、 ときには望ましいことではない。 したがって、 本発明者らは、 特 公平 5— 5 0 9 4 6号公報に開示された発明では必要な放射線量の増加を必要と せず、 そして特公平 5 - 5 0 9 4 6号公報に開示された発明で得られるような少 ない工程により透析器の滅菌ができる方法を提供するという技術的課題に直面し たのである。 Furthermore, Japanese Patent Publication No. 5-509496 discloses a method in which a hollow fiber type blood processor and an oxygen scavenger are both sealed in a container made of a gas impermeable material and irradiated with radiation for sterilization. Have been. Examples of the radiation include gamma rays (Claim 2), and examples of the blood processor include a blood processor using a regenerated cellulose hollow fiber membrane (Claim 5). According to the present invention, oxygen in the container is absorbed by the oxygen scavenger, and is in an oxygen-free state during sterilization (column 4, line 10, line 15). This publication does not mention that the absence of oxygen during sterilization reduces the sterilization effect. Increasing the radiation dose is sometimes undesirable because radiation also affects the material of the dialyzer. Therefore, the present inventors did not require the necessary increase in radiation dose in the invention disclosed in Japanese Patent Publication No. 5-50964, and disclosed the invention in Japanese Patent Publication No. 5-509946. As small as can be obtained with the disclosed invention. They faced the technical challenge of providing a method that could sterilize the dialyzer with no steps.

発明の開示 Disclosure of the invention

本発明者らによると、 滅菌効果は、 ガンマ一線照射中の酸素ラジカルの形成に より得られ、 酸素ラジカルがバクテリアに影響を与え、 殺すことにより得られる ことが観察され、 さらに、 鋭意検討の結果、 滅菌効果は、 酸素濃度のレベルが低 くとも得られることが見いだされた。 すなわち、 滅菌効果は酸素濃度は 0 . 1 % より上、 好ましくは 0 . 2 %より上、 さらに好ましくは 1 %もしくはその上であ れば、 本質的な変化がなかったのである。  According to the present inventors, it has been observed that the sterilization effect is obtained by the formation of oxygen radicals during gamma ray irradiation, and that oxygen radicals are obtained by influencing and killing bacteria. It was found that the sterilization effect was obtained even at low oxygen levels. That is, there was no substantial change in the sterilization effect if the oxygen concentration was above 0.1%, preferably above 0.2%, more preferably 1% or above.

一方で、 滅菌中に形成される酸素ラジカルは、 透析器、 特に再生セルロースを 材料とする透析器の場合、 材料に影響を与え、 アルデヒドを生成する場合がある。 これに対して、 本発明者らは、 低減された酸素濃度下で滅菌を行うと、 滅菌効果 を維持しつつ、 不所望の副生成物の生成が押さえられることをも見いだしたので ある。 すなわち、 低減された酸素濃度は 4— 5 %より下、 好ましくは 2 %より下、 さらに好ましくは 1 %もしくはその下であれば、 優れた製造条件となるのである。 このようにして本発明者らは本発明に到達したのであり、 本発明の効果は滅菌 のための放射線照射により生成するアルデヒド類のような有害な物質によつて説 明することができる。 すなわち、 本発明の低減された酸素雰囲気での殺菌によれ ば、 そのような有害な生成物はほとんど生成されなかったのである。 さらに放射 線殺菌は、 後に酸素の影響下で有害な生成物を生成することになる反応を開始さ せるかもしれない。  On the other hand, oxygen radicals formed during sterilization can affect the material of dialysis machines, especially in the case of dialysis machines made from regenerated cellulose, and may generate aldehydes. On the other hand, the present inventors have also found that performing sterilization under a reduced oxygen concentration can suppress the generation of unwanted by-products while maintaining the sterilization effect. That is, when the reduced oxygen concentration is lower than 4-5%, preferably lower than 2%, and more preferably 1% or lower, excellent production conditions are obtained. Thus, the present inventors have reached the present invention, and the effects of the present invention can be explained by harmful substances such as aldehydes generated by irradiation for sterilization. That is, according to the sterilization in the reduced oxygen atmosphere of the present invention, almost no such harmful products were generated. In addition, radiation sterilization may initiate a reaction that will later produce harmful products under the influence of oxygen.

先行技術には、 医療用具を提供するにあたってのこの技術的課題、 低減された 酸素濃度で殺菌することによって、 有害な生成物の形成を最小量とし、 しかしな 力くら、 殺菌効果を維持するという、 すなわち組合わされた課題を扱ったものはな い。 さらに、 長期の貯蔵中における低減された酸素濃度により、 長期の貯蔵中の 有害な生成物の生成も最小量とすることができるのである。 すべては、 他の材料 を導入することなく、 あるいは二重の包装体を用いることもなく、 酸素不透過の 包材の中で行われるのである。  The prior art states that this technical challenge in providing medical devices, the sterilization with reduced oxygen concentration, minimizes the formation of harmful products, but maintains the sterilization effect without much power. That is, none deal with the combined issues. Furthermore, the reduced oxygen concentration during long-term storage also minimizes the production of harmful products during long-term storage. Everything is done in an oxygen-impermeable wrapping material without introducing other materials or using double wrapping.

すなわち、 本発明の第 1の目的は、 医療用具と脱酸素剤を酸素不透過性の包材 に収納して包装体とする工程;包装体内の雰囲気を酸素濃度が低減された状態に 維持しながら、 包装体に放射線滅菌を行う工程;放射線滅菌後、 包装体の滅菌状 態を維持しながら、 さらに脱酸素剤によって酸素濃度を低減する工程;を含む、 医療用具包装体を滅菌する方法を提供することである。 この方法で製造された製 品は、 放射線滅菌による滅菌の効率を維持しながら、 滅菌中、 酸素雰囲気が低減 されていること、 さらにその後の貯蔵中、 酸素濃度が低減されていることにより、 有害な副生成物の生成を押さえることができ、 したがって、 これにより照射量の 増加を避けることができたのである。 That is, the first object of the present invention is to provide a medical device and an oxygen absorber in an oxygen-impermeable packaging material. A step of performing radiation sterilization on the package while maintaining the atmosphere in the package at a reduced oxygen concentration; maintaining the sterilized state of the package after the radiation sterilization A method of sterilizing a medical device package, further comprising a step of reducing the oxygen concentration with a deoxidizer. Products manufactured in this manner are harmful due to the reduced oxygen atmosphere during sterilization while maintaining the efficiency of sterilization by radiation sterilization, and the reduced oxygen concentration during subsequent storage. It was possible to suppress the generation of by-products, and thus to avoid an increase in irradiation dose.

好ましくは、 低減された酸素濃度は 0 . 1 %より上、 好ましくは 0 . 2 %より 上、 さらに好ましくは 1 %もしくはその上である。 さらに、 低減された酸素濃度 は 5 %より下、 好ましくは 4 %より下、 さらに好ましくは 2 %より下、 さらに好 ましくは 1 %もしくはその下である。 さらに、 滅菌後の低減された酸素濃度は 0 . 1 %より下である。  Preferably, the reduced oxygen concentration is above 0.1%, preferably above 0.2%, more preferably at or above 1%. Further, the reduced oxygen concentration is below 5%, preferably below 4%, more preferably below 2%, even more preferably 1% or below. Furthermore, the reduced oxygen concentration after sterilization is below 0.1%.

この方法は、 低減された酸素濃度雰囲気下において包装体を密閉すること、 及 び脱酸素剤を破断手段のような開口手段を有する密封された包材中に封入するこ と、 そして、 包装体を低減された酸素濃度の下で放射線殺菌し、 次いで破断手段 を破断して脱酸素剤を包装体内部の雰囲気にさらして、 さらに酸素濃度を低減さ せて実施することができる。 破断手段は、 放射線滅菌の影響によって壊れるもの を用いてもよい。  The method comprises sealing the package under a reduced oxygen concentration atmosphere, and encapsulating the oxygen scavenger in a sealed packaging material having opening means such as breaking means; and Can be carried out by radiation sterilization under a reduced oxygen concentration, then breaking the breaking means and exposing the oxygen absorber to the atmosphere inside the package to further reduce the oxygen concentration. The breaking means may be one that breaks under the influence of radiation sterilization.

しかしながら、 本発明の好ましい方法は、 脱酸素剤を徐放性の包材に封入する 方法であり、 これにより包装体の酸素濃度を一定に、 ある速度で低減することが でき、 酸素濃度が上記した好ましい値まで減少したときに包装体を照射する。 こ の方法は、 非常に好ましい製造条件を与えるものであり、 非常に限定された製造 工程により、 改良された方法を提供するものである。 本発明はまた、 上記に記載 した方法により製造された製品にも関する。  However, a preferred method of the present invention is a method in which the oxygen scavenger is sealed in a sustained-release packaging material, whereby the oxygen concentration of the package can be reduced at a constant rate at a certain rate. The package is illuminated when reduced to the desired value. This method provides very favorable manufacturing conditions and provides an improved method with very limited manufacturing steps. The invention also relates to a product made by the method described above.

図面の簡単な説明  BRIEF DESCRIPTION OF THE FIGURES

図 1は、 本発明に係る医療用具包装体の一実施例を上部から示した図、 図 2は、 本発明に係る医療用具包装体の一実施例を側面から示した図、 図 3は、 脱酸素剤包材に使用される積層体の一態様を模式化して示した断面図、 5 図 4は、 本発明に係る医療用具包装体の他の実施例を側面から示した図である。 発明を実施するための最良の形態 FIG. 1 is a diagram showing an embodiment of the medical device package according to the present invention from above, FIG. 2 is a diagram showing an embodiment of the medical device package according to the present invention from the side, FIG. Sectional view schematically showing one embodiment of the laminate used for the oxygen scavenger packaging material, 5 FIG. 4 is a side view of another embodiment of the medical device package according to the present invention. BEST MODE FOR CARRYING OUT THE INVENTION

本発明の好ましい実施態様では、 酸素不透過性材質の包材中に医療用具と遅効 性の脱酸素剤包材とが共に封入されている。  In a preferred embodiment of the present invention, the medical device and the delayed-acting oxygen scavenger packaging material are both enclosed in a packaging material made of an oxygen-impermeable material.

上記の遅効性の脱酸素剤包材とは、 比較的小さな通気性が安定して得られる通 気性の包材に脱酸素剤を収納したものであって、 放射線滅菌のときの医療用具包 装体の酸素濃度を、 0 . 1 %より上、 好ましくは 0 . 2 %より上、 さらに好まし くは 1 %もしくはその上であり、 かつ、 5 %より下、 好ましくは 4 %より下、 さ らに好ましくは 2 %より下、 さらに好ましくは 1 %もしくはその下に制御するも のであり、 放射線滅菌 2週間後の酸素濃度を 0 . 1 %より下に制御するものをい ラ  The above-mentioned delayed-acting oxygen scavenger packaging material is a gas-permeable packaging material in which a relatively small air permeability can be obtained stably, in which the oxygen scavenger is stored, and the medical device packaging for radiation sterilization. The body has an oxygen concentration above 0.1%, preferably above 0.2%, more preferably at or above 1%, and below 5%, preferably below 4%. More preferably, the oxygen concentration is controlled to be less than 2%, more preferably 1% or less, and the oxygen concentration after 2 weeks of radiation sterilization is controlled to be less than 0.1%.

なお、 放射線滅菌は、 通常、 医療用具の生産完了から 3日後〜 7日後程度の期 間内に行われている。 上記においては、 放射線滅菌が生産完了から 5日後に行わ れるものとして包材中の酸素濃度を記載した。 これは、 脱酸素剤包装体の遅効性 の程度を示すための基準として採用したものであって、 放射線滅菌を封入から 5 日後に行うべきことを意味するものではない。  Radiation sterilization is usually performed within 3 to 7 days after the completion of the production of medical devices. In the above, the oxygen concentration in the packaging material is described assuming that radiation sterilization is performed 5 days after the completion of production. This was adopted as a criterion to indicate the degree of delayed action of the oxygen scavenger package and does not mean that radiation sterilization should be performed 5 days after encapsulation.

酸素濃度は、 例えば、 包材を構成する材料の通気性を制御することによって実 現でき、 従来、 積層体分野において用いられている合成高分子又は天然高分子か ら成る各種樹脂フィルム、 織布、 不織布等から所望の通気性を有する材料を 1種 選択して行ってもよいし、 これらの材料を適宜組み合わせて積層体とし所望の通 気性を得るようにしてもよい。 また、 必要に応じて積層体の一部の層又は各層に 通気孔を設けて所望の通気性を得るようにしてもよい。 各層の厚みは適宜、 設定 される。  The oxygen concentration can be realized, for example, by controlling the air permeability of the material constituting the packaging material, and various types of resin films made of synthetic polymers or natural polymers, woven fabrics conventionally used in the field of laminates One material having desired air permeability may be selected from nonwoven fabrics and the like, or these materials may be appropriately combined to form a laminate to obtain desired air permeability. Further, if necessary, a ventilation hole may be provided in some or each layer of the laminate to obtain a desired air permeability. The thickness of each layer is appropriately set.

通気性の制御のしゃすさ及び脱酸素剤が包材外に漏れ出す危険性が小さい点か らは、 図 3に示すように、 内層開孔プラスチックフィルム 6 (以下、 内層フィル ムと称する) 、 断面通気性シート 7及び外層プラスチックフィルム 8 (以下、 外 層フィルムと称する) をこの順に、 脱酸素剤を収納した包材内側から積層したも のであって、 外層フィルムには通気孔を設けず、 包材端部断面の断面通気性シー ト露出部からの通気するか、 又は外層フィルムに内層フィルムょりも開孔率の小 さい通気孔を設けることによってさらに通気性を付与して通気性を制御する構造 の積層体を少なくとも包材の一部に使用したものが好ましい。 As shown in Fig. 3, the inner layer perforated plastic film 6 (hereinafter referred to as the inner layer film), because of its low breathability and low danger of the oxygen scavenger leaking out of the packaging material. A cross-sectional breathable sheet 7 and an outer layer plastic film 8 (hereinafter, referred to as an outer layer film) are laminated in this order from the inside of the packaging material containing the oxygen scavenger. Ventilate through the exposed section of the air-permeable sheet at the end section of the packaging material, or reduce the porosity of the outer film to the inner film. It is preferable that a laminated body having a structure in which ventilation is further provided by providing a ventilation hole to control the ventilation is used for at least a part of the packaging material.

外層フィルムに通気孔を設ける場合には、 開孔率 (外層フィルム全面積に占め る開孔面積の割合) を 1 %未満にすることが好ましい。 内層フィルムの開孔率は 特に限定されるものではないが、 通常、 1〜1 0 %である。  When vents are provided in the outer layer film, the porosity (the ratio of the open area to the total area of the outer layer film) is preferably less than 1%. The porosity of the inner layer film is not particularly limited, but is usually 1 to 10%.

脱酸素剤包材は、 これが適用される種々の大きさの物品包装体内の酸素を、 良 好な保存性が得られるための一定の脱酸素所要期間内、 放射線滅菌の 2週間後に おいて 1 %以下まで吸収除去するために、 脱酸素剤封入時に物品包装体内に 存在する酸素量に合わせて脱酸素剤量及びこれを包装する包材の寸法、 通気性を 変えたものを使用する。  The oxygen scavenger packaging material is used to reduce the oxygen in the various sizes of packaged goods to which it is applied within two weeks after radiation sterilization within a certain period of deoxidation required to obtain good preservability. In order to absorb and remove to less than or equal to%, the oxygen absorber, the size of the packaging material used for packaging the oxygen absorber, and the air permeability must be changed according to the amount of oxygen present in the article package when the oxygen absorber is enclosed.

本発明の医療器具包装体に用いられる遅効性脱酸素剤包材に好適な通気性は、 通気性の尺度として脱酸素剤包材の透湿度を P (m g/ 2 4 H r s ) 、 医療器具 包装体内に包装時に存在する酸素量を V (m l ) とした場合、 次の関係式で示さ れる値 Kが 1 0以下であることが好ましく、 8以下であることがより好ましい。  The air permeability suitable for the delayed-acting oxygen absorber packaging material used in the medical device package of the present invention is as follows: the moisture permeability of the oxygen absorber packaging material is P (mg / 24 Hrs) as a measure of air permeability; Assuming that the amount of oxygen present in the package at the time of packaging is V (ml), the value K represented by the following relational expression is preferably 10 or less, more preferably 8 or less.

K - P/V 1 / 3 K-P / V 1/3

脱酸素剤包材の透湿度 Pは、 脱酸素剤包材の内容物 (脱酸素剤) の代わりに無 水塩化カルシウムを充填したものを試料とし、 2 5 °C以下、 7 5 % R Hに調湿さ れたデシケ一夕一内に保存して、 2 4時間後の試料 1個当たり重量増分を測定す ることにより求められる。  The moisture permeability P of the oxygen scavenger packaging material was determined by filling a sample filled with anhydrous calcium chloride in place of the oxygen scavenger packaging material (oxygen scavenger) at 25 ° C or lower and 75% RH. Determined by storing within a desiccated overnight humidified condition and measuring the weight gain per sample 24 hours later.

内層フィルム及び外層フィルムの材料としては、 エチレン、 プロピレン、 ブテ ン、 ペンテン、 へキセンなどのォレフィン類のポリマー、 塩化ビニル、 塩化ビニ リデン、 酢酸ビニル、 ビニルアルコール、 アクリル酸エステル、 メタアクリル酸 エステル、 ァクリロ二トリル、 スチレンなどのビニル化合物のポリマー、 ブタジ ェン、 イソプレンなどのジォレフィン類のポリマー及びこれらのコポリマーや、 ポリアミ ド類、 ポリエステル類などが挙げられる。 これらのうち、 外層フィルム には、 ポリエステル、 ポリアミ ド、 ポリオレフィンが好ましく、 内層フィルムに は、 熱溶着による製袋が容易なように、 外層フィルムより融点の低いポリオレフ ィン又はビニル化合物のポリマーが好ましい。 外層フィルムにはポリエステルが より好ましく、 内層フィルムにはポリエチレンがより好ましく用いられる。 断面通気性シートとは、 積層可能なシート状であり、 少なくともその厚みの内 部で平面方向に通気性を有するものであり、 好ましくは紙又は不織布が用いられ 外層フィルムの内面又は外面には印刷層を設けてもよく、 また、 任意の位置に 補強層などを設けてもよい。 Materials for the inner layer film and the outer layer film include polymers of olefins such as ethylene, propylene, butene, pentene, and hexene, vinyl chloride, vinylidene chloride, vinyl acetate, vinyl alcohol, acrylate, and methacrylate. And polymers of vinyl compounds such as acrylonitrile and styrene, polymers of diolefins such as butadiene and isoprene and copolymers thereof, polyamides and polyesters. Of these, polyester, polyamide, and polyolefin are preferred for the outer layer film, and polymers of polyolefin or vinyl compound having a lower melting point than the outer layer film are preferred for the inner layer film so that bag making by heat welding is easy. . Polyester is more preferably used for the outer layer film, and polyethylene is more preferably used for the inner layer film. The cross-sectional breathable sheet is a laminate-like sheet that has air permeability in the plane direction at least inside the thickness thereof, and is preferably made of paper or nonwoven fabric, and is printed on the inner surface or outer surface of the outer layer film. A layer may be provided, and a reinforcing layer or the like may be provided at an arbitrary position.

積層体は開孔プラスチックフィルム側を内側として折り曲げ又は 2枚重ね、 脱 酸素剤を封入し、 封止して三方シール袋又は四方シール袋とする。 また、 この積 層体に脱酸素剤を封入し、 非通気性プラスチックフィルムを重ねて封止し、 四方 シール袋としてもよい。  The laminate shall be folded or laminated with the perforated plastic film inside, sealed with an oxygen scavenger, and sealed to form a three-sided or four-sided sealed bag. In addition, a deoxygenating agent may be sealed in the laminated body, and a non-breathable plastic film may be stacked and sealed to form a four-side seal bag.

封止は接着剤を用いて行ってもよいが、 プラスチックフィルムをシーラントと して熱融着することが好ましい。  The sealing may be performed using an adhesive, but it is preferable to heat seal the plastic film as a sealant.

脱酸素剤としては、 従来、 当分野において用いられている各種化合物を用いる ことができるカ^ 鉄粉を主剤とするものが好ましい。 脱酸素剤には、 更に、 多孔 質担体に水分を含浸させた水分供与体、 活性炭、 シリカなどの補助剤を適宜選択 して加えてもよい。  As the oxygen scavenger, those mainly containing iron powder, which can use various compounds conventionally used in this field, are preferable. Further, an auxiliary such as a water donor impregnated with water on a porous carrier, activated carbon, or silica may be appropriately selected and added to the oxygen scavenger.

酸素不透過性材質の包材としては、 従来、 積層体分野において用いられている 任意のもの、 例えば、 金属箔、 金属蒸着膜、 金属酸化物蒸着膜、 ガラス蒸着膜、 塩化ビニリデン系合成樹脂、 酢酸ビニリデン系合成樹脂、 ァクリロ二トリル系合 成樹脂などの層を少なくとも 1層含むものが使用できる。 使用のしゃすさ及び効 率の面からは、 例えば、 外層がナイロン、 中間層が E V O H (エチレン酢酸ビニ ル重合体、 ケン化物) 、 内層がポリェチレンの積層体;外層がナイ口ン、 中間層 がポリビニルアルコール、 内層にポリエチレンの積層体;外層がポリエステル、 中間層がアルミニゥム箔、 内層がポリェチレンの積層体などが好ましい。  As the packaging material of the oxygen-impermeable material, any material conventionally used in the field of laminates, for example, a metal foil, a metal deposition film, a metal oxide deposition film, a glass deposition film, a vinylidene chloride synthetic resin, Those containing at least one layer of a vinylidene acetate-based synthetic resin, an acrylonitrile-based synthetic resin, or the like can be used. In terms of ease and efficiency of use, for example, the outer layer is made of nylon, the intermediate layer is a laminate of EVOH (ethylene vinyl acetate polymer, saponified), the inner layer is a laminate of polyethylene, the outer layer is nylon, and the intermediate layer is A laminate of polyvinyl alcohol, an inner layer of polyethylene; an outer layer of polyester, an intermediate layer of aluminum foil, and an inner layer of polyethylene are preferred.

医療用具は特に限定されないが、 本発明の効果を考えると、 従来、 放射線滅菌 には適さないとされていた人工透析器、 特に中空糸膜型の再生セルロース膜、 特 にセルロースァセテ一ト膜を用いた人工透析器や、 酸素による劣化などの悪影響 を受けやすい、 例えばプラスチック部分を有する医療用具がふさわしい。  Although the medical device is not particularly limited, considering the effects of the present invention, an artificial dialyzer which has conventionally been considered unsuitable for radiation sterilization, particularly a regenerated cellulose membrane of a hollow fiber membrane type, particularly a cellulose acetate membrane Suitable for use are artificial dialysers that use dialysis and medical devices that are susceptible to adverse effects such as deterioration due to oxygen.

滅菌方法としては、 放射線滅菌が用いられ、 これらの中でもコスト面からガン マー線滅菌が好ましい。 実施例 Radiation sterilization is used as a sterilization method. Among them, gamma ray sterilization is preferable from the viewpoint of cost. Example

以下に本発明の医療用具包装体を添付図面に示す好適な実施例を参照しつつ、 説明する。 図 1及び図 2は本発明に係る医療用具包装体の一実施例を角度を変え て示した図である。 図 1及び図 2に示すように医療用具 1の本体は、 脱酸素剤包 材 2と共に酸素不透過性材質の包材中に密封されている。  Hereinafter, the medical device package of the present invention will be described with reference to preferred embodiments shown in the accompanying drawings. 1 and 2 are views showing one embodiment of the medical device package according to the present invention at different angles. As shown in FIGS. 1 and 2, the main body of the medical device 1 is sealed together with the oxygen-absorbing material 2 in an oxygen-impermeable material.

まず、 包材の底部側 5に使用される酸素不透過性のラミネートシート (ペアフ レックス F A 2 9 I 商品名、 呉羽化学 (株) 製品) がロールから引出され、 ヒ 一ターで加熱され、 エアーで金型に押し付けられ図 2に示すような医療用具封入 部を有する凹型に成形される。  First, an oxygen-impermeable laminate sheet (Pairflex FA29I trade name, manufactured by Kureha Chemical Co., Ltd.) used on the bottom side 5 of the packaging material is drawn out of the roll, heated by a heater, and air-heated. And pressed into a mold to form a concave shape with a medical device enclosure as shown in FIG.

次に自動投入機によって脱酸素剤包材 2 (エージレス Z— 3 0 0 P Kガ、 包装 体の透湿度 3 O m g/ 2 4 H r商品名、 三菱ガス化学 (株) 製品) が包材ボトム 部 5の中央に入れられる。 続いて、 医療用具がその上に入れられ、 包材トップ部 3に使用される酸素不透過性のラミネートシート (ボブロン、 商品名、 呉羽化学 (株) 製品) が、 ロールから引出され包材ボトム部 5と重ね合わされ、 周りを熱 融着によって封止して密封される (密封時の酸素量約 1 2 0 m l ) 。  Next, the oxygen scavenger packaging material 2 (Ageless Z—300 PK gas, moisture permeability of the package 3 O mg / 24 Hr, trade name, product of Mitsubishi Gas Chemical Co., Ltd., manufactured by Mitsubishi Gas Chemical Co., Ltd.) is automatically loaded by the automatic feeding machine. Put in the center of part 5. Next, the medical device is placed on top of it, and the oxygen-impermeable laminate sheet (Boblon, trade name, product of Kureha Chemical Co., Ltd.) used for the packaging material top 3 is pulled out of the roll and the packaging material bottom It is overlapped with the part 5, and the periphery is sealed and sealed by heat sealing (the amount of oxygen at the time of sealing is about 120 ml).

アルデヒドの生成  Aldehyde formation

医療用具としてセルロースアセテートの中空糸膜型の人工透析器を用い、 2 5 K G yのガンマ一線照射後、 人工透析器内にアルデヒド類の生成がどの程度認め られるかについて、 本実施例の遅効性脱酸素剤包装体を封入したものと封入して いないもの、 及び従来の窒素ガス置換処理されたものについて比較した。  Using a cellulose acetate hollow fiber membrane-type artificial dialyzer as a medical device, and after irradiating 25 KGy of gamma rays, the effect of this example on the degree of aldehyde generation in the artificial dialyzer A comparison was made between the case where the oxygen scavenger package was sealed, the case where the package was not sealed, and the case where the conventional nitrogen gas replacement treatment was performed.

なお、 本実施例の医療用具包装体の酸素不透過性材質の包材中の酸素濃度は、 放射線滅菌時においては 1 %、 滅菌後 2週間後においては 0 . 1 %以下であった。  The oxygen concentration in the packaging material of the oxygen-impermeable material of the medical device package of this example was 1% at the time of radiation sterilization, and 0.1% or less two weeks after the sterilization.

方法  Method

上記 3種類の試験用サンプルは、 各々はじめに 1 5 0 0 m 1の蒸留水で血液側 のみプライミング洗浄する。 その後、 3 7 °Cの蒸留水 5 0 0 m lを血液側のみ流 量 4 0 0 m l /m i nで 6時問循環させる。 この抽出液を検体とする。  First, each of the above three test samples is primed and washed with 150 ml of distilled water only on the blood side. Thereafter, 500 ml of distilled water at 37 ° C is circulated at 6:00 at a flow rate of 400 ml / min only on the blood side. This extract is used as a specimen.

ァセトアルデヒド及びホルムアルデヒドをヒドラゾン誘導体とし、 固定相にォ クチル基を充填したカラムと移動相にァセトニトリル/水系を用いた逆相高速液 体クロマトグラフィーにより測定を行う。 手順 The measurement is performed by reversed-phase high-performance liquid chromatography using acetoaldehyde and formaldehyde as hydrazone derivatives, a column packed with octyl groups in the stationary phase, and acetonitrile / water as the mobile phase. procedure

1) 4. Omlの検体と 2. 0m 1のヒドラジン試薬 (0. 2 gの 2, 4 ·ジニ トロフエニノレヒドラジンを 2M - HC 1で溶解して 500 mlにしたもの) を混 合する。  1) Mix 4. ml of the sample with 2.0 ml of the hydrazine reagent (0.2 g of 2,4-dinitropheninolehydrazine dissolved in 2M-HC1 to 500 ml).

2 ) 前処理用力一トリッジ S e p - P a k C 1 8に混合液を注ぎ、 カートリッジ を通過させる。 2) Pour the mixed solution into the pre-treatment cartridge Sep-Pak C18 and let it pass through the cartridge.

3) 蒸留水で洗い (5m 1 X 2回) 、 1. 6 m 1のァセトニトリルで溶出させる c 3) Wash with distilled water (2 x 5m1), elute with 1.6m1 of acetonitrile c

4) この溶出液を液体クロマトグラフィーで測定する。 4) Measure the eluate by liquid chromatography.

液体クロマトグラフィ一測定条件: Liquid chromatography-Measurement conditions:

移動相 —ァセトニトリル/水  Mobile phase—acetonitrile / water

流速 一 1. 7 m 1 / m i n  Flow velocity 1.7 m 1 / m i n

力ラム温度 一 25。C  Power ram temperature 1-25. C

波長 - 340 nm  Wavelength-340 nm

注入量 - 1 0 ^ 1  Injection volume-1 0 ^ 1

濃度調整 — 0m i n、 ァセトニトリル 35 %  Concentration adjustment — 0 min, acetonitrile 35%

6m i n、 ァセトニトリル 80 %  6min, acetonitrile 80%

7 m i n、 ァセトニトリノレ 35 %  7 min, acetonitrile 35%

結果を表 1に示す。  Table 1 shows the results.

表 1 p pm)

Figure imgf000011_0001
上記の比較試験の結果から、 本実施例によれば、 遅効性の脱酸素剤包材を使用 することによって、 アルデヒド類の生成を低減させることができることが明らか である。 (Table 1 p pm)
Figure imgf000011_0001
From the results of the above comparative tests, it is clear that according to the present example, the production of aldehydes can be reduced by using a delayed-acting oxygen scavenger packaging material.

本実施例によれば、 酸素不透過性の材質の包材を使用することにより外部から の酸素の進入は殆ど考えなくてよい。 また、 密封時包材中に存在していた酸素は 同時に封入した遅効性の脱酸素剤包材によって吸収され、 包材内部は使用直前に 包材を開封されるまでほぼ完全に無酸素状態に保つことができる。 According to the present embodiment, by using a packaging material made of an oxygen-impermeable material, There is almost no need to consider the ingress of oxygen. Also, the oxygen present in the packaging material at the time of sealing is absorbed by the enclosed slow-acting oxygen absorber packaging material at the same time, and the interior of the packaging material is almost completely oxygen-free until the packaging material is opened immediately before use. Can be kept.

これによつて医療用具包装体において酸化による副成物の生成、 例えば中空糸 膜型のセルロースァセテ一ト膜を用いた人工透析器においては酸化によるアルデ ヒドの生成を防止することができて、 使用者である患者に悪影響を及ぼす可能性 が低減でき、 より安全な製品を提供することができる。 また経時的なプラスチッ ク素材の強度低下も同時に防ぐことができる。  As a result, it is possible to prevent the formation of by-products due to oxidation in the medical device package, for example, the formation of aldehydes due to oxidation in an artificial dialysis machine using a hollow fiber membrane-type cellulose acetate membrane. Therefore, the possibility of adversely affecting the patient who is the user can be reduced, and a safer product can be provided. In addition, it is possible to prevent the strength of the plastic material from decreasing over time.

また、 通常の脱酸素剤包材を使用した場合は、 ガンマ一線滅菌を行う前に脱酸 素が完了してしまい滅菌効果に影響を与える場合が出てくるおそれがある力 本 実施例では遅効性の脱酸素剤包材を用 、て照射時に確実に酸素が残存しているの で、 余裕をもって医療用具生産終了から滅菌工程へ移すことができる。 しかもこ の一連の作業は大きく簡素化され、 その生産性は飛躍的に高まると考えられる。 脱酸素剤なし、 窒素ガス置換、 脱酸素剤使用の 3方法の効果の違いを表 2にま とめて示した。 なお、 従来脱酸素剤とは、 ガス透過性の包材に脱酸素剤を収納し たものである。 In addition, when ordinary oxygen scavenger packaging is used, deoxidation is completed before performing gamma linear sterilization, and the sterilization effect may be affected. Since oxygen is reliably left at the time of irradiation by using a neutral oxygen-absorbing material packaging material, the production of medical devices can be transferred to the sterilization process with a margin. Moreover, this series of operations is greatly simplified, and the productivity is expected to increase dramatically. Table 2 summarizes the differences in the effects of the three methods: no oxygen scavenger, nitrogen gas replacement, and oxygen scavenger use. The conventional oxygen absorber is a gas permeable packaging material containing the oxygen absorber.

表 2 Table 2

Figure imgf000013_0001
Figure imgf000013_0001

図 4は、 本発明に係る医療用具包装体の他の実施例を示した図である。 脱酸素 剤包材 2 ' は、 開口手段として破断ピン 9を有している。 外側のフィルムは酸素 不透過性であり、 破断ピン 9を壊して、 脱酸素剤包材 2 ' の内部を包装体トップ 部 3と包装体ボトム部 5からなる包装体内部の酸素雰囲気にさらすまでは、 酸素 は脱酸素剤包材 2 ' 中に入ることはできない。  FIG. 4 is a view showing another embodiment of the medical device package according to the present invention. The oxygen scavenger packaging material 2 ′ has a breaking pin 9 as an opening means. The outer film is impervious to oxygen and breaks the breaking pin 9 until the interior of the oxygen absorber 2 ′ is exposed to the oxygen atmosphere inside the package consisting of the package top 3 and package bottom 5. The oxygen cannot enter the oxygen scavenger 2 '.

産業上の利用可能性 Industrial applicability

本発明によれば、 経時的酸化による医療用具からの副成物、 例えばセルロース ァセテ一卜の中空糸膜型の人工透析器においてはアルデヒド類の生成がおさえら れた、 安全な医療用具包装体が供給される。  ADVANTAGE OF THE INVENTION According to this invention, the by-product from a medical device by time-dependent oxidation, for example, the production | generation of aldehydes was suppressed in the hollow fiber membrane type artificial dialyzer of a cellulose acetate, The safe medical device package. Is supplied.

Claims

請求の範囲 The scope of the claims 1 . 医療用具と脱酸素剤を酸素不透過性の包材に収納して包装体とする工程; 包装体内の雰囲気を酸素濃度が低減された状態に維持しながら、 包装体に放射線 滅菌を行う工程;放射線滅菌後、 包装体の滅菌状態を維持しながら、 さらに脱酸 素剤によって酸素濃度を低減する工程;を含む、 医療用具包装体を滅菌する方法。 1. A step of storing a medical device and a deoxidizer in an oxygen-impermeable packaging material to form a package; performing radiation sterilization on the package while maintaining the atmosphere in the package with a reduced oxygen concentration. A method of sterilizing a medical device package, comprising: a step of reducing the oxygen concentration with a deoxidizing agent while maintaining the sterilized state of the package after radiation sterilization. 2 . 放射線滅菌を行う工程における低減された酸素濃度が 0 . 1 %より上、 好 ましくは 0 . 2 %より上、 さらに好ましくは 1 %もしくはその上である請求項 1 に記載の方法。  2. The method according to claim 1, wherein the reduced oxygen concentration in the step of performing radiation sterilization is above 0.1%, preferably above 0.2%, more preferably 1% or above. 3 . 放射線滅菌を行う工程における低減された酸素濃度が 5 %より下、 好まし くは 4 %より下、 さらに好ましくは 2 %より下、 さらに好ましくは 1 %もしくは その下である請求項 2に記載の方法。  3. The method according to claim 2, wherein the reduced oxygen concentration in the step of performing radiation sterilization is below 5%, preferably below 4%, more preferably below 2%, more preferably below 1%. The described method. 4 . 低減された酸素濃度雰囲気下において包装体を密閉することによって、 低 減された酸素濃度を得、 密封後、 実質的にただちに包装体を放射線滅菌する請求 項 1、 2または 3に記載の方法。  4. The package according to claim 1, 2, or 3, wherein a reduced oxygen concentration is obtained by sealing the package in a reduced oxygen concentration atmosphere, and the package is radiation-sterilized substantially immediately after sealing. Method. 5 . 脱酸素剤は開口手段を有する密封された包材中に封入されており、 脱酸素 剤を包装体内部の雰囲気にさらすために、 放射線滅菌後、 開口手段を動作させる 請求項 4に記載の方法。  5. The oxygen absorber is enclosed in a sealed packaging material having an opening means, and the opening means is operated after radiation sterilization to expose the oxygen absorber to the atmosphere inside the package. the method of. 6 . 開口手段が破断手段であり、 開口手段を動作させる工程が破断手段を壊す 工程を含む請求項 5に記載の方法。  6. The method of claim 5, wherein the opening means is a breaking means, and wherein the actuating the opening means comprises breaking the breaking means. 7 . 開口手段が放射線滅菌により動作される請求項 6に記載の方法。  7. The method according to claim 6, wherein the opening means is operated by radiation sterilization. 8 . 脱酸素剤が徐放性の包材に封入された遅効性脱酸素剤包材であり、 遅効性 脱酸素剤包材によつて酸素濃度が前記の低減された酸素濃度まで低減した後、 放 射線滅菌を行う請求項 1、 2または 3に記載の方法。  8. The oxygen-absorbing agent is a delayed-acting oxygen absorber packaged in a sustained-release packaging material, and after the oxygen concentration has been reduced to the reduced oxygen concentration by the delayed-acting oxygen absorber. 4. The method according to claim 1, 2 or 3, wherein radiation sterilization is performed. 9 . 医療用具が再生セルロース材料を含むものである請求項 1 一 8のいずれか に記載の方法。  9. The method according to claim 18, wherein the medical device comprises a regenerated cellulose material. 10. 医療用具が透析器である請求項 9に記載の方法。  10. The method according to claim 9, wherein the medical device is a dialyzer. 11. 請求項 1 一 1 0のいずれかに記載の方法により得られた製品。  11. A product obtained by the method according to any one of claims 110. 12. 脱酸素剤と共に酸素不透過性の包材に収納され、 低減された酸素濃度にお いて放射線滅菌された、 滅菌医療用具包装体。 12. Stored in oxygen-impermeable packaging with oxygen absorbers to reduce oxygen concentration And radiation sterilized, sterile medical device packaging. 13. 脱酸素剤が開口手段を備えた包材に封入されている請求項 1 2に記載の滅 菌医療用具包装体。  13. The sterilized medical device package according to claim 12, wherein the oxygen scavenger is enclosed in a packaging material provided with an opening means. 14. 開口手段が破断手段である請求項 1 3に記載の滅菌医療用具包装体。  14. The sterilized medical device package according to claim 13, wherein the opening means is a breaking means. 15. 開口手段が放射線滅菌によって破断する材料からなる請求項 1 3に記載の 滅菌医療用具包装体。  15. The sterilized medical device package according to claim 13, wherein the opening means is made of a material that can be broken by radiation sterilization. 16. 脱酸素剤が徐放性の包材に封入された遅効性脱酸素剤包材である請求項 1 2に記載の滅菌医療用具包装体。  16. The sterilized medical device package according to claim 12, wherein the oxygen scavenger is a delayed-acting oxygen scavenger packaging material enclosed in a sustained-release packaging material. 17. 遅効性脱酸素剤包材が通気性を有する包材に脱酸素剤を収納したものであ り、 放射線滅菌のときの医療用具包装体の酸素濃度を、 0. 1 %より上、 好まし くは 0. 2%より上、 さらに好ましくは 1 %もしくはその上であり、 かつ、 5% より下、 好ましくは 4%より下、 さらに好ましくは 2%より下、 さらに好ましく は 1 %もしくはその下に制御するものであり、 放射線滅菌 2週間後の酸素濃度を 0. 1 %より下に制御するものである請求項 1 6に記載の滅菌医療用具包装体。  17. The delayed-acting oxygen absorber packaging material contains an oxygen absorber in a gas-permeable packaging material. The oxygen concentration of the medical device package during radiation sterilization should be higher than 0.1%. Preferably above 0.2%, more preferably 1% or above, and below 5%, preferably below 4%, more preferably below 2%, even more preferably 1% or above. 17. The sterilized medical device package according to claim 16, wherein the oxygen concentration after two weeks of radiation sterilization is controlled to be lower than 0.1%. 18. 遅効'【生脱酸素剤包材の一部または全部が、 脱酸素剤を収納した内側から開 孔プラスチックフィルム /断面通気性シ一トダプラスチックフィルムの順に積層 した積層体からなり、 かつ包材端部の少なくとも一方に積層体の断面部を有する 包材であって、 包材の通気性制御が、 前記包材端部に露出した断面通気性シート の断面部からの通気を制御することで行われる力、、 または前記断面部からの通気 に加え、 前記積層体表面のブラスチックフィルムに開孔プラスチックフィルムの 開孔率より小さい開孔率の通気孔を設けて通気を制御することによつて行われる 請求項 1 6に記載の滅菌医療用具包装体。  18. Slow effect '[A part or all of the raw oxygen scavenger packaging material consists of a laminated body laminated in this order from the inside containing the oxygen scavenger to the perforated plastic film / cross section breathable sheet plastic film. A packaging material having a cross-section of the laminate on at least one of the ends of the packaging material, wherein the ventilation control of the packaging material controls the ventilation from the cross-section of the cross-sectional ventilation sheet exposed at the packaging material end. In addition to the force performed in the above, or the ventilation from the cross section, the ventilation is controlled by providing ventilation holes having a pore ratio smaller than the pore ratio of the perforated plastic film in the plastic film on the surface of the laminate. The sterilized medical device package according to claim 16, wherein the package is performed. 19. 放射線滅菌が医療用具包装体の密封後 3日後から 7日後の間に行われる請 求項 1 7または 1 8に記載の滅菌医療用具包装体。  19. The sterilized medical device package according to claim 17, wherein radiation sterilization is performed between 3 days and 7 days after the sealing of the medical device package. 20. 遅効性脱酸素剤包材の包材当たりの透湿度を P (mg/24H r s) 、 医 療用具包装体密封時の包装体内酸素量を V (ml) としたとき、 次式で表される 値 が 1 0以下であるように遅効性脱酸素剤包材の通気性が制御された請求項 1 9の滅菌医療用具包装体。  20. When the moisture permeability of the delayed-acting oxygen scavenger packaging material is P (mg / 24H rs) and the oxygen content in the package when the medical device package is sealed is V (ml), the following formula is used. The sterilized medical device package according to claim 19, wherein the ventilation of the delayed-acting oxygen absorber packaging material is controlled so that the value to be obtained is 10 or less. K=P/VI 3 K = P / V I 3 21. 医療用具が再生セルロース材料を含むものである請求項 1 2— 2 0のいず れかに記載の滅菌医療用具包装体。 21. The sterilized medical device package according to any one of claims 12 to 20, wherein the medical device contains a regenerated cellulose material. 22. 医療用具が透析器である請求項 2 1に記載の滅菌医療用具包装体。  22. The sterilized medical device package according to claim 21, wherein the medical device is a dialyzer.
PCT/JP1998/002735 1997-06-20 1998-06-19 Method for sterilizing packages of medical supplies Ceased WO1998058842A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU80360/98A AU8036098A (en) 1997-06-20 1998-06-19 Method for sterilizing packages of medical supplies

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16402697 1997-06-20
JP9/164026 1997-06-20

Publications (1)

Publication Number Publication Date
WO1998058842A1 true WO1998058842A1 (en) 1998-12-30

Family

ID=15785398

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP1998/002735 Ceased WO1998058842A1 (en) 1997-06-20 1998-06-19 Method for sterilizing packages of medical supplies

Country Status (2)

Country Link
AU (1) AU8036098A (en)
WO (1) WO1998058842A1 (en)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002000699A (en) * 2000-06-23 2002-01-08 Jms Co Ltd Packaging materials for medical devices
JP2003245526A (en) * 2001-12-19 2003-09-02 Toray Ind Inc Hollow fiber membrane, method for manufacturing the same, hollow fiber membrane module and method for manufacturing the same
WO2006016575A1 (en) * 2004-08-10 2006-02-16 Toyo Boseki Kabushiki Kaisha Highly water permeable hollow fiber membrane-type blood purifier and process for producing the same
WO2006041125A1 (en) * 2004-10-15 2006-04-20 Nipro Corporation Method of hemopurifier sterilization and hemopurifier package
EP1518564A3 (en) * 2003-09-24 2006-10-04 Nipro Corporation Hollow fiber blood-processing device and method for packaging and sterilizing such devices
WO2006104082A1 (en) * 2005-03-28 2006-10-05 Toyo Boseki Kabushiki Kaisha Packaged module for blood purification and method of sterilizing the same
JP2010017712A (en) * 2001-12-19 2010-01-28 Toray Ind Inc Hollow fiber membrane and hollow fiber membrane module
US7837042B2 (en) 2004-08-10 2010-11-23 Nipro Corporation Polysulfone type selectively permeable hollow fiber membrane module and process for manufacturing the same
US8319195B2 (en) 2003-06-12 2012-11-27 Safe Haven, Inc. Methods and apparatus for sterilization of air and objects
EP1834655A4 (en) * 2004-12-22 2014-12-17 Nipro Corp BLOOD CLEANER PACK AND METHOD FOR THE PRODUCTION THEREOF
US9050410B2 (en) 2004-10-15 2015-06-09 Nipro Corporation Blood purifier and blood purifier package
WO2015194668A1 (en) * 2014-06-20 2015-12-23 旭化成メディカル株式会社 Neutrophil removal column
JP2016007235A (en) * 2014-06-20 2016-01-18 旭化成メディカル株式会社 Package of granulocyte remover for extracorporeal circulation applied with radiation
JP2017023681A (en) * 2015-07-17 2017-02-02 アイオン株式会社 Method of sterilizing polyvinyl acetal resin porous body and packaging body for sterilization
JP2017137062A (en) * 2016-02-01 2017-08-10 株式会社常盤産業 Bag body and package
JP2017159026A (en) * 2016-02-05 2017-09-14 ビー.ブラウン アビタム アーゲーB. Braun Avitum Ag Filter module packaging unit
JP2017164486A (en) * 2016-02-05 2017-09-21 ビー.ブラウン アビタム アーゲーB. Braun Avitum Ag Filter module packaging unit
EP3184446A4 (en) * 2014-08-22 2018-03-21 Terumo Kabushiki Kaisha Method for manufacturing packaged medical tool
WO2018181793A1 (en) 2017-03-29 2018-10-04 共同印刷株式会社 Oxygen absorptive film, packaging laminated body and packaging body using oxygen absorptive film, and method for processing contents using packaging body

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6326010B2 (en) * 1980-10-17 1988-05-27 Dainippon Printing Co Ltd
JPH01267130A (en) * 1988-04-13 1989-10-25 Toppan Printing Co Ltd Method for disinfecting packaging material
JPH0318371A (en) * 1989-06-15 1991-01-25 Nippon Medical Supply Corp Radiation sterilization method for medical tools
JPH0349807B2 (en) * 1982-03-10 1991-07-30 Unitika Ltd
JPH0550946B2 (en) * 1986-03-03 1993-07-30 Nisso Kk

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6326010B2 (en) * 1980-10-17 1988-05-27 Dainippon Printing Co Ltd
JPH0349807B2 (en) * 1982-03-10 1991-07-30 Unitika Ltd
JPH0550946B2 (en) * 1986-03-03 1993-07-30 Nisso Kk
JPH01267130A (en) * 1988-04-13 1989-10-25 Toppan Printing Co Ltd Method for disinfecting packaging material
JPH0318371A (en) * 1989-06-15 1991-01-25 Nippon Medical Supply Corp Radiation sterilization method for medical tools

Cited By (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002000699A (en) * 2000-06-23 2002-01-08 Jms Co Ltd Packaging materials for medical devices
JP2010017712A (en) * 2001-12-19 2010-01-28 Toray Ind Inc Hollow fiber membrane and hollow fiber membrane module
JP2003245526A (en) * 2001-12-19 2003-09-02 Toray Ind Inc Hollow fiber membrane, method for manufacturing the same, hollow fiber membrane module and method for manufacturing the same
US8319195B2 (en) 2003-06-12 2012-11-27 Safe Haven, Inc. Methods and apparatus for sterilization of air and objects
EP1518564A3 (en) * 2003-09-24 2006-10-04 Nipro Corporation Hollow fiber blood-processing device and method for packaging and sterilizing such devices
AU2004212619B2 (en) * 2003-09-24 2009-12-17 Nipro Corporation Hollow fiber blood-processing device and method for packaging and sterilizing such devices
US8211362B2 (en) 2003-09-24 2012-07-03 Nipro Corporation Packaged blood purification device
US7837042B2 (en) 2004-08-10 2010-11-23 Nipro Corporation Polysulfone type selectively permeable hollow fiber membrane module and process for manufacturing the same
JP4848278B2 (en) * 2004-08-10 2011-12-28 東洋紡績株式会社 Highly permeable hollow fiber membrane blood purifier and method for producing the same
WO2006016575A1 (en) * 2004-08-10 2006-02-16 Toyo Boseki Kabushiki Kaisha Highly water permeable hollow fiber membrane-type blood purifier and process for producing the same
JP2006110164A (en) * 2004-10-15 2006-04-27 Toyobo Co Ltd Blood purifier sterilization method and blood purifier package
US10137234B2 (en) 2004-10-15 2018-11-27 Nipro Corporation Method for sterilizing blood purifier and blood purifier package
WO2006041125A1 (en) * 2004-10-15 2006-04-20 Nipro Corporation Method of hemopurifier sterilization and hemopurifier package
US9987409B2 (en) 2004-10-15 2018-06-05 Nipro Corporation Blood purifier and blood purifier package
US9050410B2 (en) 2004-10-15 2015-06-09 Nipro Corporation Blood purifier and blood purifier package
US9056280B2 (en) 2004-10-15 2015-06-16 Nipro Corporation Method for sterilizing blood purifier and blood purifier package
US9067178B2 (en) 2004-12-22 2015-06-30 Nipro Corporation Blood purifier package and process for manufacturing the same
EP1834655A4 (en) * 2004-12-22 2014-12-17 Nipro Corp BLOOD CLEANER PACK AND METHOD FOR THE PRODUCTION THEREOF
EP2962712A1 (en) 2004-12-22 2016-01-06 Nipro Corporation Hemopurifier package and process for producing the same
EP3437670A1 (en) 2004-12-22 2019-02-06 Nipro Corporation Hemopurifier package and process for producing the same
US9987408B2 (en) 2004-12-22 2018-06-05 Nipro Corporation Blood purifier package and process for manufacturing the same
WO2006104082A1 (en) * 2005-03-28 2006-10-05 Toyo Boseki Kabushiki Kaisha Packaged module for blood purification and method of sterilizing the same
JPWO2015194668A1 (en) * 2014-06-20 2017-04-20 旭化成メディカル株式会社 Neutrophil removal column
WO2015194668A1 (en) * 2014-06-20 2015-12-23 旭化成メディカル株式会社 Neutrophil removal column
JP2016007235A (en) * 2014-06-20 2016-01-18 旭化成メディカル株式会社 Package of granulocyte remover for extracorporeal circulation applied with radiation
EP3184446A4 (en) * 2014-08-22 2018-03-21 Terumo Kabushiki Kaisha Method for manufacturing packaged medical tool
JP2017023681A (en) * 2015-07-17 2017-02-02 アイオン株式会社 Method of sterilizing polyvinyl acetal resin porous body and packaging body for sterilization
JP2017137062A (en) * 2016-02-01 2017-08-10 株式会社常盤産業 Bag body and package
JP2017159026A (en) * 2016-02-05 2017-09-14 ビー.ブラウン アビタム アーゲーB. Braun Avitum Ag Filter module packaging unit
JP2017164486A (en) * 2016-02-05 2017-09-21 ビー.ブラウン アビタム アーゲーB. Braun Avitum Ag Filter module packaging unit
JP7009065B2 (en) 2016-02-05 2022-01-25 ビー.ブラウン アビタム アーゲー Filter module packaging unit
WO2018181793A1 (en) 2017-03-29 2018-10-04 共同印刷株式会社 Oxygen absorptive film, packaging laminated body and packaging body using oxygen absorptive film, and method for processing contents using packaging body
JPWO2018181793A1 (en) * 2017-03-29 2019-12-12 共同印刷株式会社 Oxygen-absorbing film, packaging laminate and packaging using the same, and content processing method using the packaging
EP3603965A4 (en) * 2017-03-29 2020-11-25 Kyodo Printing Co., Ltd. OXYGEN-ABSORBING FILM, LAMINATED PACKAGING BODY, AND PACKAGING BODY WITH OXYGEN-ABSORBING FILM, AND METHOD OF PROCESSING CONTENTS USING A PACKAGING BODY

Also Published As

Publication number Publication date
AU8036098A (en) 1999-01-04

Similar Documents

Publication Publication Date Title
WO1998058842A1 (en) Method for sterilizing packages of medical supplies
JP6676647B2 (en) Self-sterilizing package and method of making and using the same
JPH11500393A (en) How to package medical articles
US20090236253A1 (en) Sterilized package, method for its production, and its use in medicine
JPS62204754A (en) Radiation sterilization of medical instrument
JP2005169008A (en) Method of sterilizing biocompatible material
CN101072594B (en) Sterilization method of blood purifier and package body of blood purifier
JP2876320B2 (en) Radiation sterilization method for medical equipment
GB1569479A (en) Sterile artifical kidney dialyzer package
CN112407588A (en) Films and packages for gas or vapour decontaminated packaging and methods for their use
JPH05221461A (en) Packaging bag
CN101102802A (en) Blood purifier package and method for producing same
US5241803A (en) Ozone sterilization method and product
JPH0889561A (en) Method for sterilizing articles containing plastic by irradiation with radiation or electron beams
JPWO1998058842A1 (en) Sterilization method for medical device packaging
JP2505329B2 (en) Package for storing chemical solutions containing bicarbonate compounds
JP2901669B2 (en) Manufacturing method of radiation sterilized medical device
JP2001190639A (en) Medical container
JP3252647B2 (en) Liquid processor
JPS6326010B2 (en)
JPS6031695B2 (en) Sterile packaging method
JP2003144523A (en) Plural-chamber container
JP2941318B2 (en) Manufacturing method of radiation sterilized medical device
JPH10216200A (en) Preparation of container for medical treatment
JPH01158958A (en) Sterilization of medical utensil by radiation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA